These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 22799296)
1. Lack of association between the hOGG1 Ser326Cys polymorphism and gastric cancer risk: a meta-analysis. Li BR; Zhou GW; Bian Q; Song B Asian Pac J Cancer Prev; 2012; 13(4):1145-9. PubMed ID: 22799296 [TBL] [Abstract][Full Text] [Related]
2. An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis. Ji C; Liu Z; Chen H; Guo H; Liu C BMC Cancer; 2012 Aug; 12():335. PubMed ID: 22857644 [TBL] [Abstract][Full Text] [Related]
3. The functional Ser326Cys polymorphism in hOGG1 is associated with gastric cancer risk: evidence from 1180 cases and 2444 controls. Ni M; Qiu J; He W; Wang X Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):683-7. PubMed ID: 22343785 [TBL] [Abstract][Full Text] [Related]
4. Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects. Xu Z; Yu L; Zhang X Diagn Pathol; 2013 Aug; 8():144. PubMed ID: 23971971 [TBL] [Abstract][Full Text] [Related]
5. Lack of association between the hOGG1 gene Ser326Cys polymorphism and gastric cancer risk: evidence from a case-control study and a meta-analysis. Hu WG; Pan RJ; Cai W; Wang ZT; Zhu ZG Genet Mol Res; 2015 Nov; 14(4):14670-9. PubMed ID: 26600527 [TBL] [Abstract][Full Text] [Related]
6. No association between hOGG1 Ser326Cys polymorphism and hepatocellular carcinoma. Zhen-Bo T; An-Lin F; Ling L; Su-Fang Z Hepatogastroenterology; 2013; 60(125):1101-4. PubMed ID: 23186590 [TBL] [Abstract][Full Text] [Related]
7. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis. Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the association between hOGG1 Ser326Cys polymorphism and risk of colorectal cancer based on case--control studies. Guo CL; Han FF; Wang HY; Wang L J Cancer Res Clin Oncol; 2012 Sep; 138(9):1443-8. PubMed ID: 22526153 [TBL] [Abstract][Full Text] [Related]
9. Association of the hOGG1 Ser326Cys polymorphism with gynecologic cancer susceptibility: a meta-analysis. Shi Y; Xu W; Zhang X Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33210702 [TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of the association between the hOGG1 Ser326Cys polymorphism and the risk of esophageal squamous cell carcinoma. Zhang J; Zhou J; Zhang P; Wang W; Tao S; Wang M PLoS One; 2013; 8(6):e65742. PubMed ID: 23762419 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk. Zhong DY; Chu HY; Wang ML; Ma L; Shi DN; Zhang ZD Genet Mol Res; 2012 Sep; 11(3):3490-6. PubMed ID: 23079842 [TBL] [Abstract][Full Text] [Related]
12. The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis. Wei B; Zhou Y; Xu Z; Xi B; Cheng H; Ruan J; Zhu M; Hu Q; Wang Q; Wang Z; Yan Z; Jin K; Zhou D; Xuan F; Huang X; Shao J; Lu P PLoS One; 2011; 6(11):e27545. PubMed ID: 22114677 [TBL] [Abstract][Full Text] [Related]
13. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies. Wang W; Wang M; Chen Y; Zhang Z; Wang S; Xu M; Wang B; Zhao Q; Zhang Z Mutagenesis; 2012 May; 27(3):329-36. PubMed ID: 22121210 [TBL] [Abstract][Full Text] [Related]
14. The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls. Zhang H; Xu Y; Zhang Z; Li L BMC Cancer; 2011 Sep; 11():391. PubMed ID: 21914193 [TBL] [Abstract][Full Text] [Related]
15. Smoking and hOGG1 Ser326Cys polymorphism contribute to lung cancer risk: evidence from a meta-analysis. Yin ZB; Hua RX; Li JH; Sun C; Zhu JH; Su X; Ji C; Xiang Q; Hua ZM Tumour Biol; 2014 Feb; 35(2):1609-18. PubMed ID: 24085357 [TBL] [Abstract][Full Text] [Related]
16. Association of hOGG1 Ser326Cys polymorphism with colorectal cancer risk: an updated meta-analysis including 5235 cases and 8438 controls. Zhang M; Mo R Tumour Biol; 2014 Dec; 35(12):12627-33. PubMed ID: 25227662 [TBL] [Abstract][Full Text] [Related]
17. Association of hOGG1 Ser326Cys polymorphism with gastric cancer risk: a meta-analysis. Niu Y; Li F; Tang B; Shi Y; Yu P Mol Biol Rep; 2012 Jun; 39(6):6563-8. PubMed ID: 22294108 [TBL] [Abstract][Full Text] [Related]
18. Association of Base Excision Repair Gene hOGG1 Ser326Cys Polymorphism with Susceptibility to Cervical Squamous Cell Carcinoma and High-Risk Human Papilloma Virus Infection in a Chinese Population. Chen H; Wang H; Liu J; Cheng Q; Chen X; Ye F Genet Test Mol Biomarkers; 2019 Feb; 23(2):138-144. PubMed ID: 30648893 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis. Zhang RC; Mou SH Tumour Biol; 2013 Apr; 34(2):901-7. PubMed ID: 23271362 [TBL] [Abstract][Full Text] [Related]
20. The hOGG1 Ser326Cys polymorphism contributes to digestive system cancer susceptibility: evidence from 48 case-control studies. Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X Tumour Biol; 2015 Feb; 36(2):1029-38. PubMed ID: 25323581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]